160
Views
83
CrossRef citations to date
0
Altmetric
Original Research

Sustained-release nanoART formulation for the treatment of neuroAIDS

, , , , &
Pages 1077-1093 | Published online: 04 Feb 2015

References

  • WilliamsIChurchillDAndersonJBritish HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012HIV Med201213suppl 2185
  • García de OlallaPKnobelHCarmonaAGuelarALópez-ColomésJLCaylàJAImpact of adherence and highly active antiretroviral therapy on survival in HIV-infected patientsJ Acquir Immune Defic Syndr200230110511012048370
  • NowacekAGendelmanHENanoART, neuroAIDS and CNS drug deliveryNanomedicine (Lond)20094555757419572821
  • BangsbergDRPerrySCharleboisEDNon-adherence to highly active antiretroviral therapy predicts progression to AIDSAIDS20011591181118311416722
  • Adherence to HIV Antiretroviral TherapyHIV InSite Knowledge Base Chapter2005 [reviewed January 2006]. Available from: http://hivinsite.ucsf.edu/insite?page=kb-03-02-09Accessed December 20, 2014
  • KellyJAKalichmanSCBehavioral research in HIV/AIDS primary and secondary prevention: recent advances and future directionsJ Consult Clin Psychol200270362663912090373
  • MartinLRWilliamsSLHaskardKBDimatteoMRThe challenge of patient adherenceTher Clin Risk Manag20051318919918360559
  • KovochichMMarsdenMDZackJAActivation of latent HIV using drug-loaded nanoparticlesPLoS ONE201164e1827021483687
  • ArchinNMEspesethAParkerDCheemaMHazudaDMargolisDMExpression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acidAIDS Res Hum Retroviruses200925220721219239360
  • ThomasSAAnti-HIV drug distribution to the central nervous systemCurr Pharm Des200410121313132415134483
  • AyreSGNew approaches to the delivery of drugs to the brainMed Hypotheses19892942832912685524
  • BhaskarSTianFStoegerTMultifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood–brain barrier: perspectives on tracking and neuroimagingPart Fibre Toxicol201071320199661
  • PardridgeWMBlood–brain barrier deliveryDrug Discov Today2007121–2546117198973
  • SagarVPilakka-KanthikeelSPottathilRSaxenaSKNairMTowards nanomedicines for neuroAIDSRev Med Virol201424210312424395761
  • SaiyedZMGandhiNHNairMPMagnetic nanoformulation of azidothymidine 5′-triphosphate for targeted delivery across the blood–brain barrierInt J Nanomedicine2010515716620463931
  • VaratharajanLThomasSAThe transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further researchAntiviral Res2009822A99A10919176219
  • BoffitoMJacksonAOwenABeckerSNew approaches to antiretroviral drug delivery: challenges and opportunities associated with the use of long-acting injectable agentsDrugs201474171324327298
  • DingHSagarVAgudeloMEnhanced blood–brain barrier transmigration using a novel transferrin embedded fluorescent magneto-liposome nanoformulationNanotechnology201425505510124406534
  • NairMGuduruRLiangPHongJSagarVKhizroevSExternally controlled on-demand release of anti-HIV drug using magneto-electric nanoparticles as carriersNat Commun20134170723591874
  • Pilakka-KanthikeelSAtluriVSRSagarVSaxenaSKNairMTargeted brain derived neurotropic factors (BDNF) delivery across the blood–brain barrier for neuro-protection using magnetic nano carriers: an in vitro studyPLoS ONE201384e6224123653680
  • WohlfartSGelperinaSKreuterJTransport of drugs across the blood–brain barrier by nanoparticlesJ Control Release2012161226427321872624
  • SunYMaMZhangYGuNSynthesis of nanometer-size maghemite particles from magnetiteColloids Surf A Physicochem Eng Asp20042451–31519
  • DecherGFuzzy nanoassemblies: Toward layered polymeric multicompositesScience1997277533012321237
  • AtluriVSRKanthikeelSPReddyPVYndartANairMPHuman synaptic plasticity gene expression profile and dendritic spine density changes in HIV-infected human CNS cells: role in HIV-associated neurocognitive disorders (HAND)PLoS ONE201384e6139923620748
  • TodukaYToyookaTIbukiYFlow cytometric evaluation of nanoparticles using side-scattered light and reactive oxygen species-mediated fluorescence-correlation with genotoxicityEnviron Sci Technol201246147629763622703531
  • PersidskyYStinsMWayDA model for monocyte migration through the blood–brain barrier during HIV-1 encephalitisJ Immunol19971587349935109120312
  • GandhiNSaiyedZMNapuriJInteractive role of human immunodeficiency virus type 1 (HIV-1) clade-specific Tat protein and cocaine in blood–brain barrier dysfunction: implications for HIV-1-associated neurocognitive disorderJ Neurovirol201016429430520624003
  • AtluriVSPilakka-KanthikeelSSamikkannuTVorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive disorderMol Brain2014713724886748
  • JayantRLayer-by-Layer (LbL) assembly of anti HIV drug for sustained release to brain using magnetic nanoparticlesJ Neuroimmune Pharmacol20149125
  • JayantRDMcShaneMJSrivastavaRPolyelectrolyte-coated alginate microspheres as drug delivery carriers for dexamethasone releaseDrug Deliv200916633134019606947
  • KargolAMalkinskiLCaruntuGBiomedical applications of multiferroic nanoparticlesMalkinskiLAdvanced Magnetic MaterialsRijeka, CroatiaIntech200689118
  • CaragliaMDe RosaGSalzanoGNanotech revolution for the anti-cancer drug delivery through blood–brain barrierCurr Cancer Drug Targets201212318619622268384
  • De RosaGSalzanoGCaragliaMAbbruzzeseANanotechnologies: a strategy to overcome blood–brain barrierCurr Drug Metab2012131616922292810
  • KaushikAJayantRDSagarVNairMThe potential of magneto-electric nanocarriers for drug deliveryExpert Opin Drug Deliv201411101635164624986772
  • JayantRDSrivastavaRDexamethasone release from uniform sized nanoengineered alginate microspheresJ Biomed Nanotechnol200733245253